Sleep Medication Options for Elderly Patients
First-Line Options
- The American Academy of Sleep Medicine recommends suvorexant (15 mg) as the first-line medication for insomnia in elderly patients due to its favorable efficacy and safety profile, with moderate-strength evidence showing improvements in sleep maintenance and sleep onset 1, 3
- Suvorexant has demonstrated a 55% response rate (vs 42% with placebo) based on Insomnia Severity Index improvement, with somnolence (7% vs 3% with placebo) being the main side effect 3
Second-Line Options
- Low-dose doxepin (3-6 mg) is recommended for sleep maintenance insomnia with improvements in total sleep time and wake after sleep onset, according to the American Academy of Sleep Medicine 1
- Eszopiclone (1-2 mg) is effective for both sleep onset and maintenance issues, but requires dose reduction in elderly patients, as suggested by the American Academy of Sleep Medicine 4
Medications to Avoid
- The American Academy of Sleep Medicine advises against the use of benzodiazepines in elderly patients due to increased risk of falls, cognitive impairment, and potential association with dementia 1, 5
- Trazodone is not recommended due to weak evidence for efficacy in insomnia and potential for significant side effects, including priapism, orthostatic hypotension, and daytime sedation, as stated by the American Academy of Sleep Medicine 2
- Ramelteon showed limited efficacy in clinical trials with minimal improvements in sleep onset and no improvement in total sleep time in older adults, according to the American Academy of Sleep Medicine 1, 3
Treatment Algorithm
- The American Academy of Sleep Medicine suggests starting with suvorexant 15 mg taken 30 minutes before bedtime, and evaluating efficacy after 2-4 weeks of consistent use 1, 3, 4
- If inadequate response, consider adding cognitive behavioral therapy for insomnia (CBT-I) or switching to low-dose doxepin (3-6 mg) if sleep maintenance is the primary issue, as recommended by the American Academy of Sleep Medicine 4, 2